Search results
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks· 6 days agoNovavax’s filing is based on guidance from the FDA issued last week, which advised COVID-19 vaccine manufacturers Moderna (MRNA Quick QuoteMRNA - Free Report ...
Feeling Sick After Your COVID Vaccine? According to Scientists, It’s Actually a Good Sign
SciTechDaily· 3 days agoA UCSF study suggests that side effects like headaches and chills from COVID-19 vaccines indicate a...
Column: This GOP-leaning political polling firm has turned into a purveyor of anti-vaccine...
LA Times via Yahoo News· 4 days agoBlaming the COVID vaccines for a tide of undocumented injuries and deaths is a popular theme in the...
3 No-Brainer Stocks to Buy for Under $100 Right Now | The Motley Fool
The Motley Fool· 12 hours agoHere's why they picked AstraZeneca (AZN 0.41%), Bristol Myers Squibb (BMY 2.17%), and Pfizer (PFE)....
Pfizer stock price analysis: how PFE became a fallen angel | Invezz
Invezz· 5 days agoPfizer (NYSE: PFE) stock price has crashed hard in the past few years as demand for Covid-19 ...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
...NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation COVID...
NewMediaWire via Yahoo Finance· 5 days ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen, ...
Gateway - Quartz
Quartz· 4 days agoThe company announced on Oct. 20 that it intends to sell the covid vaccine, marketed under the brand name Comirnaty, for $110 to $130 per dose. According ...
Feds try to delay release of non-public COVID vaccine safety data until at least 2026
Just the News· 3 days agoThe Biden administration is seeking to delay until at least 2026 the release of COVID-19 vaccine...
Will Pfizer Stock Rebound To Its 2021 Highs Of $60?
Forbes· 6 days agoThis underperformance of Pfizer stock can be attributed to declining revenues after the surge in Covid-19 vaccine demand during the pandemic ...